SCRIBE THERAPEUTICS
LIVE

Serial Number

97420511

Owner

Scribe Therapeutics Inc.

Attorney

John Paul Oleksiuk

First Use Date

Oct 1, 2020

Filing Date

May 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SCRIBE THERAPEUTICS Trademark

Serial Number: 97420511

SCRIBE THERAPEUTICS is a trademark filed by Scribe Therapeutics Inc. on May 20, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Scribe Therapeutics Inc. (10 trademarks)

Alameda, CA 94501

Entity Type: 03

Trademark Details

Filing Date

May 20, 2022

Registration Date

Not Registered

First Use Anywhere

October 1, 2020

First Use in Commerce

October 1, 2020

Published for Opposition

April 25, 2023

Goods & Services

Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, and therapeutic products and services; Design and development of engineered cells for use in scientific research and in drug discovery and development; Providing medical and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering; Molecular diagnostic services in the nature of genetic testing for medical research purposes

Filing History

1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jun 22, 2026 DP1B
NOTICE OF ALLOWANCE CANCELLED
Jun 20, 2026 IUCN
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jun 20, 2026 EPPA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 15, 2025 EXRA
SOU EXTENSION 5 GRANTED
Dec 15, 2025 EX5G
SOU EXTENSION 5 FILED
Dec 14, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 14, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 9, 2025 EXRA
SOU EXTENSION 4 GRANTED
Dec 9, 2025 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 9, 2025 AITU
SOU EXTENSION 4 FILED
Jun 18, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 18, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 15, 2024 EX3G
SOU EXTENSION 3 FILED
Dec 15, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 15, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 11, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 11, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 11, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 12, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 10, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 10, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 10, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 20, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 16, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 16, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 16, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 16, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 16, 2023 CNEA
ASSIGNED TO EXAMINER
Mar 9, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 25, 2022 NWOS
NEW APPLICATION ENTERED
May 24, 2022 NWAP